Format

Send to

Choose Destination
Cell Stem Cell. 2018 Mar 1;22(3):294-297. doi: 10.1016/j.stem.2018.01.015.

Human Pluripotent Stem Cell-Derived Engineered Tissues: Clinical Considerations.

Author information

1
Department of Bioengineering, University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington, Seattle, WA, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA; Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA.
2
Department of Bioengineering, University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington, Seattle, WA, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA; Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA; Department of Medicine/Cardiology, University of Washington, Seattle, WA, USA. Electronic address: murry@uw.edu.

Abstract

The combined power of human pluripotent stem cells and tissue engineering promises to revolutionize medicine by building tissue patches and artificial replacement organs for patients battling diverse diseases. Here, we articulate some big questions that need to be addressed before such engineered tissues become mainstream in the clinic.

PMID:
29499147
DOI:
10.1016/j.stem.2018.01.015

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center